Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


Living Cell Technologies trading halt for Parkinson's Trial

Living Cell Technologies in trading halt pending Parkinson's trial result

By Paul McBeth

Nov. 9 (BusinessDesk) - ASX-listed Kiwi biotech firm Living Cell Technologies is in a trading halt until tomorrow when it expects to announce the results of a clinical trial testing its treatment for Parkinson's disease.

The Melbourne-based company's Phase IIb clinical trial was completed in April and it's been waiting for the results to be unblinded, which if successful would see Living Cell apply for provisional consent and launch its NTCELL treatment for Parkinson's in 2018. It today sought a halt in trading of its shares "pending the NTCELL Parkinson's disease clinical trial results announcement" which it expected to make tomorrow.

Living Cell developed the NTCELL treatment for Parkinson’s disease using choroid plexus brain cells from neonatal pigs, which are implanted into a damaged site in the brain and then function as a “neurochemical factory” producing factors that promote new central nervous system growth and repair disease-induced nerve degeneration.

The shares last traded at 20.5 Australian cents and have soared 130 percent so far this year.

Earlier this week the company filed a provisional patent after research with the Centre for Brain Research at Auckland University to see how NTCELL can reverse neurodegenerative processes. The project was undertaken by Auckland University's commercial arm, UniServices, to see whether Living Cell could extend the pipeline of its product and generate data to help identify neuroprotective product candidates.

(BusinessDesk receives assistance from Callaghan Innovation to cover the commercialisation of innovation)


© Scoop Media

Business Headlines | Sci-Tech Headlines


Stats: Auckland’s Population Falls For The First Time
In the wake of the COVID-19 pandemic, New Zealand’s population growth slowed down with Auckland recording a population decline for the first time ever, Stats NZ said today. “New Zealand saw slowing population growth in all regions... More>>

BusinessNZ: Third Snapshot Report Reveals $9.5 Billion Business Investment In Climate Action

Signatories to the Climate Leaders Coalition have committed to invest $9.5 billion over the next five years to reduce emissions from their businesses, as revealed in their third anniversary snapshot report released today... More>>

Digitl: The home printer market is broken
Printers are more of a security blanket that a serious aid to productivity. Yet for many people they are not optional.
Even if you don’t feel the urge to squirt ink onto dead trees in order to express yourself, others will insist on printed documents... More>>

Retail NZ: Some Good News In COVID Announcements, But Firm Dates Needed

Retail NZ is welcoming news that the Government is increasing financial support for businesses in light of the ongoing COVID-19 lockdown, and that retail will be able to open at all stages of the new “Covid Protection Framework... More>>

ComCom: Companies In Hot Water For Selling Unsafe Hot Water Bottles And Toys

A wholesaler and a retailer have been fined a total of $140,000 under the Fair Trading Act for selling hot water bottles and toys that did not comply with mandatory safety requirements. Paramount Merchandise Company Limited (Paramount) was fined $104,000 after pleading guilty in the Manukau District Court... More>>

Reserve Bank: Robust Balance Sheets Yield Faster Economic Recovery

Stronger balance sheets for households, businesses, financial institutions and the government going into the pandemic contributed towards maintaining a sound financial system and yielding a faster economic recovery than following previous deep recessions... More>>